JPWO2021085582A1 - - Google Patents

Info

Publication number
JPWO2021085582A1
JPWO2021085582A1 JP2021553708A JP2021553708A JPWO2021085582A1 JP WO2021085582 A1 JPWO2021085582 A1 JP WO2021085582A1 JP 2021553708 A JP2021553708 A JP 2021553708A JP 2021553708 A JP2021553708 A JP 2021553708A JP WO2021085582 A1 JPWO2021085582 A1 JP WO2021085582A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021553708A
Other versions
JP7288074B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021085582A1 publication Critical patent/JPWO2021085582A1/ja
Application granted granted Critical
Publication of JP7288074B2 publication Critical patent/JP7288074B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2021553708A 2019-10-31 2020-10-30 ピラジン誘導体またはその塩およびその利用 Active JP7288074B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2019198280 2019-10-31
JP2019198280 2019-10-31
JP2020128831 2020-07-30
JP2020128831 2020-07-30
PCT/JP2020/040744 WO2021085582A1 (ja) 2019-10-31 2020-10-30 ピラジン誘導体またはその塩およびその利用

Publications (2)

Publication Number Publication Date
JPWO2021085582A1 true JPWO2021085582A1 (ja) 2021-05-06
JP7288074B2 JP7288074B2 (ja) 2023-06-06

Family

ID=75715271

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021553708A Active JP7288074B2 (ja) 2019-10-31 2020-10-30 ピラジン誘導体またはその塩およびその利用

Country Status (4)

Country Link
US (1) US20220259185A1 (ja)
EP (1) EP4052760B1 (ja)
JP (1) JP7288074B2 (ja)
WO (1) WO2021085582A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2022025174A1 (ja) * 2020-07-30 2022-02-03
WO2022200615A1 (en) 2021-03-26 2022-09-29 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Pyrimidine biosynthesis inhibitor combination for use in treating viral infections

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010513362A (ja) * 2006-12-22 2010-04-30 アルミラル・ソシエダッド・アノニマ Ｄｈｏｄｈ阻害剤としてのアミノニコチンおよびイソニコチン酸誘導体
WO2014069510A1 (ja) * 2012-10-31 2014-05-08 富山化学工業株式会社 新規アミン誘導体またはその塩
WO2016044666A1 (en) * 2014-09-17 2016-03-24 Epizyme, Inc. Heterocycle substituted amino-pyridine compounds and methods of use thereof
WO2018157843A1 (zh) * 2017-03-02 2018-09-07 中国科学院上海药物研究所 2-(取代苯杂基)芳香甲酸类fto抑制剂，其制备方法及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8703768B2 (en) 2010-06-09 2014-04-22 Hoffmann-La Roche Inc. Nitrogen containing heteroaryl compounds
GB201610854D0 (en) 2016-06-21 2016-08-03 Entpr Therapeutics Ltd Compounds
CA3074059A1 (en) 2017-09-01 2019-03-07 Chronos Therapeutics Limited Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives as orexin receptor antagonists

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010513362A (ja) * 2006-12-22 2010-04-30 アルミラル・ソシエダッド・アノニマ Ｄｈｏｄｈ阻害剤としてのアミノニコチンおよびイソニコチン酸誘導体
WO2014069510A1 (ja) * 2012-10-31 2014-05-08 富山化学工業株式会社 新規アミン誘導体またはその塩
WO2016044666A1 (en) * 2014-09-17 2016-03-24 Epizyme, Inc. Heterocycle substituted amino-pyridine compounds and methods of use thereof
WO2018157843A1 (zh) * 2017-03-02 2018-09-07 中国科学院上海药物研究所 2-(取代苯杂基)芳香甲酸类fto抑制剂，其制备方法及其应用

Also Published As

Publication number Publication date
EP4052760A1 (en) 2022-09-07
EP4052760B1 (en) 2024-03-13
US20220259185A1 (en) 2022-08-18
EP4052760A4 (en) 2022-11-23
WO2021085582A1 (ja) 2021-05-06
JP7288074B2 (ja) 2023-06-06

Similar Documents

Publication Publication Date Title
BR112019017762A2 (ja)
BR112021017339A2 (ja)
BR112021013854A2 (ja)
BR112021018450A2 (ja)
BR112021017892A2 (ja)
BR112019016141A2 (ja)
AU2020104490A4 (ja)
BR112021017939A2 (ja)
BR112021017738A2 (ja)
BR112021017782A2 (ja)
BR112019016138A2 (ja)
BR112019016142A2 (ja)
BR112021017728A2 (ja)
BR112021017234A2 (ja)
BR112021017355A2 (ja)
BR112021017173A2 (ja)
BR112021017083A2 (ja)
BR112021017637A2 (ja)
BR112021008711A2 (ja)
BR112021018452A2 (ja)
BR112021012348A2 (ja)
BR112021018250A2 (ja)
BR112021017703A2 (ja)
BR112021013944A2 (ja)
BR112021013128A2 (ja)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220328

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230418

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230501

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230523

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230525

R150 Certificate of patent or registration of utility model

Ref document number: 7288074

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150